Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interstitial pathomechanisms underlying progressive tubulointerstitial damage.

F Strutz1, G A Müller

  • 1Department of Nephrology and Rheumatology, Georg-August-University Medical Center, Göttingen, Germany. fstrutz@gwdg.de

Kidney & Blood Pressure Research
|June 3, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impairment of muscular endothelial cell regeneration in dermatomyositis.

Frontiers in neurology·2022
Same author

PAC-Mediated AKI Protection Is Critically Mediated but Does Not Exclusively Depend on Cell-Derived Microvesicles.

International journal of nephrology·2021
Same author

Analysis of Direct Effects of the CB1 Receptor Antagonist Rimonabant on Fatty Acid Oxidation and Glycogenolysis in Liver and Muscle Cells in vitro.

Biochemistry. Biokhimiia·2019
Same author

Early endothelial progenitor cells and vascular stiffness in psoriasis and psoriatic arthritis.

European journal of medical research·2018
Same author

Therapeutic response to glucocorticoids, anticoagulation and plasma exchange in a patient with primary antiphospholipid syndrome presenting with purpura fulminans.

Lupus·2018
Same author

Rituximab in routine care of severe active rheumatoid arthritis : A prospective, non-interventional study in Germany.

Zeitschrift fur Rheumatologie·2018
Same journal

SIRT6 attenuates angiotensin II-induced podocyte cholesterol accumulation and injury via negative modulation of SREBP2.

Kidney & blood pressure research·2026
Same journal

Epidemiology and multimorbidity in hemodialysis patients at a tertiary care center in northern Mexico: implications for hospital-based adverse outcomes.

Kidney & blood pressure research·2026
Same journal

The inflammatory milieu exacerbates Anemia of CKD:  From the gut-kidney axis to bone marrow hematopoiesis inhibition.

Kidney & blood pressure research·2026
Same journal

Cystine-binding medication is poorly accessible for the treatment of cystinuria.

Kidney & blood pressure research·2026
Same journal

Infective endocarditis-associated glomerulonephritis caused by Streptococcus cristatus: A Case Report.

Kidney & blood pressure research·2026
Same journal

Simplified Subjective Global Assessment at Hemodialysis Initiation and Its Association with 2-Year Mortality and Hospitalization.

Kidney & blood pressure research·2026
See all related articles

Chronic kidney disease (CKD) progression involves a common pathway of interstitial fibrosis and tubular atrophy. This review explores fibrogenesis mechanisms and therapeutic strategies for progressive renal failure.

Area of Science:

  • Nephrology
  • Pathology
  • Cell Biology

Background:

  • Progressive renal disease is a growing medical concern.
  • End-stage renal failure often presents with similar histologic features like interstitial infiltration, fibrosis, tubular atrophy, and dilatation, suggesting a common pathway.
  • Renal disease can advance even after the initial cause is addressed.

Purpose of the Study:

  • To review the pathomechanisms of progressive renal failure.
  • To propose a three-step model of fibrogenesis: induction, inflammation, and postinflammatory matrix synthesis.
  • To highlight the role of tubular epithelial cells in mediating inflammation and matrix synthesis.
  • To provide an overview of novel therapeutic approaches for fibrogenesis.

Main Methods:

Related Experiment Videos

  • Literature review focusing on the pathomechanisms of progressive renal failure.
  • Analysis of the three-step fibrogenesis model.
  • Discussion of the role of tubular epithelial cells.
  • Overview of emerging therapeutic strategies.

    • Main Results:

    • A three-step model of fibrogenesis (induction, inflammation, postinflammatory matrix synthesis) is proposed as a key mechanism in progressive renal disease.
    • Tubular epithelial cells play a central role in mediating interstitial inflammation and contributing to matrix synthesis.
    • Histologic similarities in chronic renal disease suggest a final common pathway regardless of the initial cause.

    Conclusions:

    • Understanding the fibrogenesis pathway, particularly the role of tubular epithelial cells, is crucial for managing progressive renal disease.
    • Novel therapeutic strategies targeting fibrogenesis hold promise for limiting the progression of kidney damage.
    • The proposed model provides a framework for future research into renal fibrosis.